Related references
Note: Only part of the references are listed.Systematic review of pharmacological interventions for people with Lewy body dementia
Katrina E. Watts et al.
AGING & MENTAL HEALTH (2023)
Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: a randomized controlled trial
Johanne B. Tonga et al.
INTERNATIONAL PSYCHOGERIATRICS (2021)
Less Is More: The Impact of Deprescribing Psychotropic Drugs on Behavioral and Psychological Symptoms and Daily Functioning in Nursing Home Patients. Results From the Cluster-Randomized Controlled COSMOS Trial
Marie H. Gedde et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2021)
Discontinuation of antipsychotics treatment for elderly patients within a specialized behavioural unit: a retrospective review
Raymond LinBin Gao et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2021)
The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An update on management of behavioral and psychological symptoms in dementia
Anderson Chen et al.
PSYCHIATRY RESEARCH (2021)
Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms
Georges Naasan et al.
BRAIN (2021)
Pharmacotherapy for Frontotemporal Dementia
Rita Khoury et al.
CNS DRUGS (2021)
Comparative efficacy of non-pharmacological interventions on agitation in people with dementia: A systematic review and Bayesian network meta-analysis
Minmin Leng et al.
INTERNATIONAL JOURNAL OF NURSING STUDIES (2020)
Effectiveness of Pharmacological Interventions for Symptoms of Behavioral Variant Frontotemporal Dementia: A Systematic Review
Calvin Trieu et al.
COGNITIVE AND BEHAVIORAL NEUROLOGY (2020)
Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management
John O'Brien et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress
Radoslaw Magierski et al.
FRONTIERS IN PHARMACOLOGY (2020)
Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review
Myrlene Sanon Aigbogun et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Treatment Options for Agitation in Dementia
John M. Ringman et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2019)
Advances in Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases
Jeffrey Cummings et al.
CURRENT PSYCHIATRY REPORTS (2019)
Comparative Efficacy of Interventions for Aggressive and Agitated Behaviors in Dementia A Systematic Review and Network Meta-analysis
Jennifer A. Watt et al.
ANNALS OF INTERNAL MEDICINE (2019)
Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementia
Rachel Halpern et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis
Boru Jin et al.
JOURNAL OF NEUROLOGY (2019)
The Pharmacology of Visual Hallucinations in Synucleinopathies
Mirella Russo et al.
FRONTIERS IN PHARMACOLOGY (2019)
Aripiprazole for the treatment of psychotic symptoms in patients with dementia with Lewy bodies: a case series
Yuka Sugawara Kikuchi et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2019)
Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia A Network Meta-analysis
Ismaeel Yunusa et al.
JAMA NETWORK OPEN (2019)
Citalopram Improves Obsessive Compulsive Crossword Puzzling in Frontotemporal Dementia
Sebastian Meyer et al.
CASE REPORTS IN NEUROLOGY (2019)
An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia
Suzanne M. Dyer et al.
INTERNATIONAL PSYCHOGERIATRICS (2018)
What Behavioral and Psychological Symptoms of Dementia Affect Caregiver Burnout?
Kazuko Hiyoshi-Taniguchi et al.
CLINICAL GERONTOLOGIST (2018)
Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial
Prasad R. Padala et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis
Khachen Kongpakwattana et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia
Simon J. C. Davies et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2018)
Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Factors Associated with the Caregivers' Desire to Institutionalize Persons with Dementia: A Cross-Sectional Study
Sophie Vandepitte et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2018)
Pharmacological interventions for apathy in Alzheimer's disease
Myuri T. Ruthirakuhan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Antidepressants for treating depression in dementia
Robert Dudas et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Valproate preparations for agitation in dementia
Sarah F. Baillon et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care
Stephen J. Ralph et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2018)
Antipsychotic Use in Dementia: Is There a Problem and Are There Solutions?
Julia Kirkham et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms
Marta Miarons et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
An update on the advancements in the treatment of agitation in Alzheimer's disease
Anton P. Porsteinsson et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
The relationship of specific items on the Neuropsychiatric Inventory to caregiver burden in dementia: a systematic review
Toril Marie Terum et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2017)
Halting Antipsychotic Use in Long-Term care (HALT): a single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia
Tiffany Jessop et al.
INTERNATIONAL PSYCHOGERIATRICS (2017)
Aripiprazole Improves Psychotic, Cognitive, and Motor Symptoms in a Patient With Lewy Body Dementia
Cho Lee et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia
Giovanni Viscogliosi et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
Antipsychotics and dementia in Canada: a retrospective cross-sectional study of four health sectors
Sebastian Rios et al.
BMC GERIATRICS (2017)
Pharmacological Therapy for Apathy in Alzheimer's Disease: A Systematic Review and Meta-Analysis
Amir A. Sepehry et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2017)
Low-dose Lithium Treatment for Agitation and Psychosis in Alzheimer Disease and Frontotemporal Dementia: A Case Series
Davangere P. Devanand et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2017)
The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis
Hisanori Kobayashi et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2016)
The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia
Victor I. Reus et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia
Radoslaw Magierski et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Only 10% of the psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study
Klaas van der Spek et al.
INTERNATIONAL PSYCHOGERIATRICS (2016)
A systematic review of the relationship between behavioral and psychological symptoms (BPSD) and caregiver well-being
Alexandra Feast et al.
INTERNATIONAL PSYCHOGERIATRICS (2016)
The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis
Qing-Fei Zhao et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia
Radoslaw Magierski et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Time Trends in Antipsychotic Drug Use in Patients with Dementia: A Nationwide Study
Ane Norgaard et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
10-year trajectories of depressive symptoms and risk of dementia: a population-based study
Saira Saeed Mirza et al.
LANCET PSYCHIATRY (2016)
Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease
Daniel Weintraub et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2015)
Circadian rhythm in Alzheimer disease after trazodone use
Talyta C. Grippe et al.
CHRONOBIOLOGY INTERNATIONAL (2015)
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia A Randomized Clinical Trial
Jeffrey L. Cummings et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Cognitive intervention therapy as treatment for behaviour disorders in Alzheimer disease: Evidence on efficacy and neurobiological correlations
J. M. Garcia-Alberca
NEUROLOGIA (2015)
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia A randomized controlled trial
Geke A. H. van den Elsen et al.
NEUROLOGY (2015)
Therapeutic Drug Monitoring of Selective Serotonin Reuptake Inhibitors in Elderly Patients
Monica Hermann et al.
THERAPEUTIC DRUG MONITORING (2015)
Antipsychotics, Other Psychotropics, and the Risk of Death in Patients With Dementia Number Needed to Harm
Donovan T. Maust et al.
JAMA PSYCHIATRY (2015)
Oxytocin for frontotemporal dementia A randomized dose-finding study of safety and tolerability
Elizabeth C. Finger et al.
NEUROLOGY (2015)
Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer's disease with behavioural and psychological symptoms of dementia: a preliminary open-label trial
Hidenobu Suzuki et al.
PSYCHOGERIATRICS (2015)
Effect of Citalopram on Agitation in Alzheimer Disease The CitAD Randomized Clinical Trial
Anton P. Porsteinsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
The Efficacy and Safety of Atypical Antipsychotics for the Treatment of Dementia: A Meta-Analysis of Randomized Placebo-Controlled Trials
Hui Ma et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
The effects of abrupt antipsychotic discontinuation in cognitively impaired older persons: A pilot study
M. Azermai et al.
AGING & MENTAL HEALTH (2013)
Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: a systematic review
Dallas P. Seitz et al.
INTERNATIONAL PSYCHOGERIATRICS (2013)
Safety and Efficacy of Methylphenidate for Apathy in Alzheimer's Disease: A Randomized, Placebo-Controlled Trial
Paul B. Rosenberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2013)
Managing abnormal eating behaviours in frontotemporal lobar degeneration patients with topiramate
Shunichiro Shinagawa et al.
PSYCHOGERIATRICS (2013)
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia
Tom Declercq et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Impact of the Food and Drug Administration's antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office-based settings
Vibha C. A. Desai et al.
ALZHEIMERS & DEMENTIA (2012)
Atypical Antipsychotic Use in Patients With Dementia: Managing Safety Concerns
Martin Steinberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Risk of Mortality Among Individual Antipsychotics in Patients With Dementia
Helen C. Kales et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Meta-Analysis of Nonpharmacological Interventions for Neuropsychiatric Symptoms of Dementia
Henry Brodaty et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Effect of Selective Serotonin Reuptake Inhibitors in Alzheimer's Disease with Comorbid Depression A Meta-Analysis of Depression and Cognitive Outcomes
Amir A. Sepehry et al.
DRUGS & AGING (2012)
The problem with problem behaviors: a systematic review of the association between individual patient behavioral and psychological symptoms and caregiver depression and burden within the dementia patient-caregiver dyad
Katherine Ornstein et al.
INTERNATIONAL PSYCHOGERIATRICS (2012)
Treatment of Indiscriminate, Inappropriate Sexual Behavior in Frontotemporal Dementia With Carbamazepine
Connie E. Poetter et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Reversal of abnormal eating and drinking behaviour in a frontotemporal lobar degeneration patient using low-dose topiramate
Peter J. Nestor
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Relapse Risk after Discontinuation of Risperidone in Alzheimer's Disease
D. P. Devanand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Temporal Relationship Between Depression and Dementia Findings From a Large Community-Based 15-Year Follow-up Study
Ge Li et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
The effects of oxytocin on social cognition and behaviour in frontotemporal dementia
Sarah Jesso et al.
BRAIN (2011)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
Antidepressants for agitation and psychosis in dementia
D. P. Seitz et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Sertraline for the Treatment of Depression in Alzheimer Disease
Paul B. Rosenberg et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Sertraline for the Treatment of Depression in Alzheimer Disease: Week-24 Outcomes
Daniel Weintraub et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Nonpharmacological Therapies in Alzheimer's Disease: A Systematic Review of Efficacy
Javier Olazaran et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
Murat Emre et al.
LANCET NEUROLOGY (2010)
Behavioural abnormalities associated with rapid deterioration of language functions in semantic dementia respond to sertraline
C. I. Prodan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Predictors of Nursing Home Admission for Persons with Dementia
Joseph E. Gaugler et al.
MEDICAL CARE (2009)
Depression as a Risk Factor or Prodromal Feature for Dementia? Findings in a Population-Based Sample of Swedish Twins
Jessica A. Brommelhoff et al.
PSYCHOLOGY AND AGING (2009)
Inappropriate Sexual Behaviors in Cognitively Impaired Older Individuals
David R. R. Guay
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY (2008)
A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease
Joel E. Streim et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: Phase 1 outcomes from the CATIE-AD effectiveness trial
David L. Sultzer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Antipsychotic therapy and short-term serious events in older adults with dementia
Paula A. Rochon et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Topiramate may modulate alcohol abuse but not other compulsive behaviors in frontotemporal dementia - Case report
Marcelo Cruz et al.
COGNITIVE AND BEHAVIORAL NEUROLOGY (2008)
Serotonin-1A receptors in frontotemporal dementia compared with controls
Krista L. Lanctot et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2007)
Secondary bipolar disorder and diogenes syndrome in frontotemporal dementia -: Behavioral improvement with quetiapine and sodium valproate
Ana Galvez-Andres et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: A multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses
Jacobo E. Mintzer et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2007)
The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials
Ira Katz et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Inappropriate sexual behaviour in a case of ALS and FTD: Successful treatment with sertraline
Johanna M. H. Anneser et al.
AMYOTROPHIC LATERAL SCLEROSIS (2007)
Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia
Craig A. Yury et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2007)
Preliminary findings: Behavioral worsening on donepezil in patients with frontotemporal dementia
Mario F. Mendez et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia - A systematic review
Liat Ayalon et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Design of depression in Alzheimer's disease study-2
Barbara K. Martin et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
Lon S. Schneider et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment
Jeffrey L. Cummings et al.
NEUROLOGY (2006)
Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials
LS Schneider et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia
S Rahman et al.
NEUROPSYCHOPHARMACOLOGY (2006)
A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia
ED Huey et al.
NEUROLOGY (2006)
An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia
Fabio Lopes Rocha et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Risk of death with atypical antipsychotic drug treatment for dementia - Meta-analysis of randomized placebo-controlled trials
LS Schneider et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Management of agitation, aggression, and psychosis associated with dementia: A pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone
PP De Deyn et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2005)
Inappropriate sexual behaviors in dementia
B Black et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2005)
Stereotypical movements and frontotemporal dementia
MF Mendez et al.
MOVEMENT DISORDERS (2005)
Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial
JB Deakin et al.
PSYCHOPHARMACOLOGY (2004)
Frontotemporal dementia: A randomised, controlled trial with trazodone
F Lebert et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2004)
Behavioural disturbances in dementia patients and quality of the marital relationship
ME de Vugt et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Frontotemporal dementia: Paroxetine as a possible treatment of behavior symptoms - A randomized, controlled, open 14-month study
R Moretti et al.
EUROPEAN NEUROLOGY (2003)
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities -: A double-blind, randomized, placebo-controlled trial
JS Street et al.
ARCHIVES OF GENERAL PSYCHIATRY (2000)
Share Paper
